These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22895698)

  • 1. Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure.
    Cao D; Xu H; Guo G; Ruan Z; Fei L; Xie Z; Wu Y; Chen Y
    Inflammation; 2013 Feb; 36(1):110-20. PubMed ID: 22895698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrahepatic expression and distribution of BTLA and its ligand HVEM in patients with HBV-related acute-on-chronic liver failure.
    Xu H; Cao D; Guo G; Ruan Z; Wu Y; Chen Y
    Diagn Pathol; 2012 Oct; 7():142. PubMed ID: 23067542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure.
    Guo G; Cao D; Xu H; Ruan Z; Fei L; Xie Z; Wu Y; Chen Y
    Pathol Int; 2012 Oct; 62(10):665-74. PubMed ID: 23005593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.
    Rong YH; Wan ZH; Song H; Li YL; Zhu B; Zang H; Zhao Y; Liu HL; Zhang AM; Xiao L; Xin SJ; You SL
    Tissue Antigens; 2014 Feb; 83(2):76-81. PubMed ID: 24397461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PD-1 expression in peripheral T cells of patients with HBV infection and its significance].
    Peng GP; Sun W; Sun Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 36(6):553-60. PubMed ID: 18067228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B.
    Wenjin Z; Chuanhui P; Yunle W; Lateef SA; Shusen Z
    BMC Gastroenterol; 2012 Aug; 12():109. PubMed ID: 22894700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure.
    Shi F; Zhang JY; Zeng Z; Tien P; Wang FS
    Biochem Biophys Res Commun; 2010 Nov; 402(1):30-6. PubMed ID: 20883666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B.
    Chen J; Wang XM; Wu XJ; Wang Y; Zhao H; Shen B; Wang GQ
    Inflamm Res; 2011 Jan; 60(1):47-53. PubMed ID: 20661763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection.
    Xie Z; Chen Y; Zhao S; Yang Z; Yao X; Guo S; Yang C; Fei L; Zeng X; Ni B; Wu Y
    Immunol Invest; 2009; 38(7):624-38. PubMed ID: 19811426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
    Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
    Tzeng HT; Tsai HF; Liao HJ; Lin YJ; Chen L; Chen PJ; Hsu PN
    PLoS One; 2012; 7(6):e39179. PubMed ID: 22761734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.
    Sherman AC; Trehanpati N; Daucher M; Davey RT; Masur H; Sarin SK; Kottilil S; Kohli A
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):665-72. PubMed ID: 23259453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68+ Cells during Chronic HBV Infection.
    Said EA; Al-Reesi I; Al-Riyami M; Al-Naamani K; Al-Sinawi S; Al-Balushi MS; Koh CY; Al-Busaidi JZ; Idris MA; Al-Jabri AA
    PLoS One; 2016; 11(6):e0158265. PubMed ID: 27348308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B.
    Zhang WJ; Peng CH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):394-9. PubMed ID: 23924497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
    Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
    Front Immunol; 2021; 12():648420. PubMed ID: 34589081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.